Morbidity and Outcome After Mechanical Ventricular Support Using Thoratec, Novacor, and HeartMate for Bridging to Heart Transplantation
Kazutomo Minami(Nihon University), Reiner Koerfer(Heart and Diabetes Center North Rhine-Westphalia), Akira Sezai(Nihon University), Peter Sarnowsky(Heart and Diabetes Center North Rhine-Westphalia), Latif Arusoglu(Heart and Diabetes Center North Rhine-Westphalia), Aly El‐Banayosy(Heart and Diabetes Center North Rhine-Westphalia), O. Fey(Heart and Diabetes Center North Rhine-Westphalia)
Cited by 94
Related Papers
Comparison of Febuxostat and Allopurinol for Hyperuricemia in Cardiac Surgery Patients (NU-FLASH Trial)
|Circulation Journal|2013|120
Effects of Canagliflozin in Patients with Type 2 Diabetes and Chronic Heart Failure: A Randomized Trial (CANDLE)
|ESC Heart Failure|2020|109
Results of Low-Dose Human Atrial Natriuretic Peptide Infusion in Nondialysis Patients With Chronic Kidney Disease Undergoing Coronary Artery Bypass Grafting
|Journal of the American College of Cardiology|2011|108
Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial
|PLoS Medicine|2020|100
Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: New evidence from the PASCAL trial
|Journal of Thoracic and Cardiovascular Surgery|2011|96